Pandemic accelerates antimicrobial resistance; Agios Pharma CEO to step down

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: 'Eye-opening': The Covid-19 pandemic accelerated antimicrobial resistance across the U.S. By Ed Silverman James Archer/CDC During the pandemic's first year, more than 29,400 people died from antimicrobial-resistant infections commonly associated with health care. Read More STAT+: Agios Pharma CEO Jackie Fouse to step down, as a former Alexion executive takes over By Adam Feuerstein Investors may interpret Fouse’s decision to vacate the CEO post as another sign Agios’s plan is not working. Read More STAT+: Verve Therapeutics begins human tests of first 'base editor,' aiming at heart disease By Matthew Herper and Megan Molteni Verve The biotech's experimental treatment is aimed at a relatively common form of high cholesterol that affects millions of people. Read More Sponsor content by STAT Events Democrats’ Last Chance for Drug Pricing Reform? The drug pricing debate remains a central conversation in Congress. On July 20, STAT sits down with key decision-makers about the latest developments from Capitol Hill and the White House. Join them. Citing risk from Omicron variant BA.5, White House urges Americans to get Covid-19 boosters By Andrew Joseph Susan Walsh/AP Health officials stressed they have tools to handle the ascendant Covid variant, even while underscoring its spread. Read More Tuesday, July 12, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser